Protocol No.: CCTL019B2003I

Title
Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) in diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release
Principal Investigator
Craig, Michael
Phase
NA
Age Group
Adult
Applicable Disease Sites
Leukemia
Lymphoma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Crystal Peck, RN
Nurse Clinician
Phone: +1 304-598-4500

View on ClinicalTrials.gov